Executive Summary

Brace Pharma Capital is a strategic investment company formed by EMS S/A, the largest pharmaceutical company in Brazil, and high net worth biotech investors. We invest in innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options.

About Brace Pharma

  • U.S. affiliate company of EMS
  • Invest 80% of portfolio funds in clinical phase projects and 20% in pre-clinical projects
  • Build fully integrated Pharma companies around projects
  • Strong Scientific Advisory Board and network with leading universities and key opinion leaders
  • Leverage EMS in Latin America
  • Out-license to European Union, China, Japan and other regions

Leveraging EMS’ Success

  • #1 Pharma company in Brazil
  • 13% of total Brazilian market share
  • Sales of $3.5B in 2013
  • 100% privately owned
  • 6,000 employees
  • 1,500 sales representatives
  • Exporting to over 40 countries